UBS Upgrades Moderna (MRNA) to Buy, 'Pipeline underappreciated'
Tweet Send to a Friend
(Updated - June 26, 2023 5:19 AM EDT)
UBS analyst Eliana Merle upgraded Moderna (NASDAQ: MRNA) from Neutral to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
UBS analyst Eliana Merle upgraded Moderna (NASDAQ: MRNA) from Neutral to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
